Biotech Values

[exwannabe]

One issue for MNTA here is timing - could be that the Amphastar process predates the MNTA patents.

It might be well documented in the FDA CMC paperwork, so the issue could be at the trial.

As a technical point, is it not the date of the MNTA invention, and not the patent application, that matters?